PharmaCorp Rx Inc. (TSXV:PCRX)
Canada
· Delayed Price · Currency is CAD 0.4800
-0.0100 (-2.04%)
Jun 27, 2025, 4:00 PM EDT
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 55.34 million as of July 1, 2025.
Market Cap
55.34M
Enterprise Value
43.55M
Revenue
9.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.48
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 55.34M, an increase of 2,205.91%. That is a compound annual growth rate of 213.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 55.34M | -12.63% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royal Bank of Canada | 250.66B |
| The Toronto-Dominion Bank | 171.32B |
| Enbridge | 133.87B |
| Brookfield | 129.03B |
| Thomson Reuters | 122.15B |
| Brookfield Asset Management | 121.99B |
| Bank of Montreal | 107.99B |
| Constellation Software | 105.61B |